Using pharmacokinetic and pharmacodynamic data in early decision making regarding drug development: A phase I clinical trial evaluating tyrosine kinase inhibitor, AEE788

José Baselga, Alain C. Mita, Patrick Schöffski, Herlinde Dumez, Frederico Rojo, Josep Tabernero, Clifford DiLea, William Mietlowski, Christie Low, Jerry Huang, Margaret Dugan, Kathryn Parker, Eric Walk, Allan Van Oosterom, Erika Martinelli, Chris H. Takimoto

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Using pharmacokinetic and pharmacodynamic data in early decision making regarding drug development: A phase I clinical trial evaluating tyrosine kinase inhibitor, AEE788'. Together they form a unique fingerprint.

Medicine & Life Sciences